Just P J Brakenhoff
Overview
Explore the profile of Just P J Brakenhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yaqub A, Mens M, Klap J, Weverling G, Klatser P, Brakenhoff J, et al.
Alzheimers Dement
. 2022 Aug;
19(4):1194-1203.
PMID: 35946915
Introduction: MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression. Their role in the pathophysiology of dementia and potential as biomarkers remains undetermined. Methods: We conducted a single- (one-by-one) and multi-marker...
2.
Mens M, Maas S, Klap J, Weverling G, Klatser P, Brakenhoff J, et al.
Front Genet
. 2020 Mar;
11:110.
PMID: 32174972
MicroRNAs (miRNAs) are non-coding RNA molecules that regulate gene expression. Extensive research has explored the role of miRNAs in the risk for type 2 diabetes (T2D) and coronary heart disease...
3.
Jones H, Ritschel T, Pascual G, Brakenhoff J, Keogh E, Furmanova-Hollenstein P, et al.
PLoS Pathog
. 2018 Mar;
14(3):e1006935.
PMID: 29509814
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants and the elderly, and yet there remains no effective treatment or vaccine. The surface...
4.
Dreyfus C, Laursen N, Kwaks T, Zuijdgeest D, Khayat R, Ekiert D, et al.
Science
. 2012 Aug;
337(6100):1343-8.
PMID: 22878502
Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the...
5.
Ekiert D, Friesen R, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al.
Science
. 2011 Jul;
333(6044):843-50.
PMID: 21737702
Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of V(H)1-69 antibodies that broadly neutralize almost all influenza A group 1 viruses constituted a...
6.
Friesen R, Koudstaal W, Koldijk M, Weverling G, Brakenhoff J, Lenting P, et al.
PLoS One
. 2010 Feb;
5(2):e9106.
PMID: 20161706
Background: The urgent medical need for innovative approaches to control influenza is emphasized by the widespread resistance of circulating subtype H1N1 viruses to the leading antiviral drug oseltamivir, the pandemic...
7.
Koudstaal W, Koldijk M, Brakenhoff J, Cornelissen L, Weverling G, Friesen R, et al.
J Infect Dis
. 2009 Nov;
200(12):1870-3.
PMID: 19911992
New strategies to prevent and treat influenza virus infections are urgently needed. A recently discovered class of monoclonal antibodies (mAbs) neutralizing an unprecedented spectrum of influenza virus subtypes may have...
8.
van den Hout J, Kamphoven J, Winkel L, Arts W, de Klerk J, Loonen M, et al.
Pediatrics
. 2004 May;
113(5):e448-57.
PMID: 15121988
Objective: Recent reports warn that the worldwide cell culture capacity is insufficient to fulfill the increasing demand for human protein drugs. Production in milk of transgenic animals is an attractive...